illmatix, I also believe there are interested parties out there. Just that the suitors want to make sure their investment is sound and will generate return on expected time line. So, it's difficult to ink a deal at this point. I think at the very least the lawsuit should be settled, and IPCI needs to get an agreement with FDA for approval under predetermined conditions such as additional testing to support abuse deterrent properties.
When you partner with a company that's got lawsuits going it's never easy to set expectations and goals to follow. And if you were to take on the lawsuit as part of the deal, that's additional resources you have to spend. So yes it's possible they have interested parties out there, but inking a deal isn't likely at the moment. ETLP is in the same boat. FDA required them to do additional trials that's planed to finish year end and submit for approval. CEO have been saying they are in talks but nothing ever happened.
News 
Market Data 
Discover 
